Cargando…
Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and remains the most common life-shortening diseases affecting the exocrine organs. The absence of this channel results in an imbalance of ion concentrations across the cell membrane an...
Autores principales: | Bardin, Pauline, Sonneville, Florence, Corvol, Harriet, Tabary, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186820/ https://www.ncbi.nlm.nih.gov/pubmed/30349480 http://dx.doi.org/10.3389/fphar.2018.01113 |
Ejemplares similares
-
Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Mitri, Christie, et al.
Publicado: (2020) -
MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology
por: Sonneville, Florence, et al.
Publicado: (2017) -
miR-636: A Newly-Identified Actor for the Regulation of Pulmonary Inflammation in Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2019) -
TMEM16A/ANO1: Current Strategies and Novel Drug Approaches for Cystic Fibrosis
por: Mitri, Christie, et al.
Publicado: (2021) -
Opposite Expression of Hepatic and Pulmonary Corticosteroid-Binding Globulin in Cystic Fibrosis Patients
por: Tchoukaev, Anastasia, et al.
Publicado: (2018)